focus -WSS

focus

author：leisure time 2025-09-30 21:22:28 - browse：13

a liver made up by geometric shapes – biotech coverage from STAT — Adobe

Intercept Pharmaceuticals, a firm whose treatment for a prevalent liver disease once made it the hottest stock in biotech, said Tuesday it would sell the company for less than $1 billion.

Alfasigma, an Italian pharmaceutical firm, will pay $19 a share for Intercept, in a roughly $800 million cash deal that represents an 80% premium to the company’s recent trading price. Intercept expects the deal to close by the end of the year.

The transaction comes three months after the Food and Drug Administration rejected Intercept’s treatment for NASH, an increasingly common fatty liver disease perceived as a potential gold mine by drug companies. Intercept’s medicine, called obeticholic acid, would have been the first approved treatment for NASH, but serious concerns about the risk of drug-related liver damage and uncertainty over whether its modest effects would improve patients’ lives made it unapprovable in the eyes of the FDA.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： 'Screen and refer' systems are hurting patients

Wikipedia

WSS

Argenx drug significantly slows progression of nerve disorder

Woman gored by Bison at Yellowstone

How Robert F. Kennedy Jr. distorted vaccine science

Global childhood vaccinations edge closer to pre

Why police arrested suspected Gilgo Beach killer away from his house

Skip the lead apron during X

Wikipedia

focus

knowledge

In age of alternative facts, a scholarly course on calling out crap

Grail faces three suits alleging harassment, retaliation

State Dept. review finds Biden bears some blame for Afghanistan failures

Skip the lead apron during X

Jerome Adams on the need for new antivirals for Covid

How Robert F. Kennedy Jr. distorted vaccine science

After affirmative action ruling, medical educators look to 'holistic review'

Fatty liver disease was alleviated by Lilly’s ‘triple

Anesthesiologist group: stop taking Ozempic before surgery

Care demand spikes challenge UnitedHealth’s provider arm

hotspot

A letter from the executive editor: The 2023 STATUS List

Manchin, Huntsman team up to talk platform for 'unity' ticket that could run in 2024

Undocumented workers face uncertainty as immigration law takes effect in Florida

Canadians with cystic fibrosis outlive Americans by a decade

Hubble vs. James Webb telescope images: See the difference

The biotech scorecard for Q3: 15 stock

focus

Wikipedia

entertainment

hotspot